Literature DB >> 22544079

Incidence, medical and socio-behavioural predictors of psychiatric events in an 11-year follow-up of HIV-infected patients on antiretroviral therapy.

Camelia Protopopescu1, François Raffi, Cécile Brunet-François, Dominique Salmon, Renaud Verdon, Philippe Reboud, Maria Patrizia Carrieri, Catherine Leport, Bruno Spire, Laurent Michel.   

Abstract

BACKGROUND: Psychiatric disorders are relatively common among HIV-infected patients. However, there are few studies about their potential risk factors. This analysis aimed to measure the incidence of severe psychiatric events (PE) among patients receiving combination antiretroviral therapy (cART) of the French APROCO-COPILOTE (ANRS CO8) cohort, and to identify the medical and socio-behavioural correlates of their first episode of depression, suicide or suicide attempt (D/S/SA).
METHODS: APROCO-COPILOTE is a cohort of patients started on a protease inhibitor regimen between 1997 and 1999, with prospective medical standardized records and self-administered questionnaires collecting socio-demographic and socio-behavioural data. This analysis included all 11-year follow-up visits for 1,095 patients having completed baseline self-administered questionnaires. A proportional hazard Cox model was used to identify the correlates of a first D/S/SA event.
RESULTS: The overall prevalence of severe PE remained low: 50 patients experienced 67 events (incidence rate [95% CI] =1.04 [0.82, 1.32] per 100 person-years). Depression (n=16), suicides (n=5) and suicide attempts (n=14) were the most frequently diagnosed PE (0.54 [0.39, 0.76] per 100 person-years) among 25 patients. Multivariate results showed that unemployment, unstable housing, detectable viral load and smoking more than 20 cigarettes/day were independently associated with D/S/SA.
CONCLUSIONS: Although the incidence of severe PE remained relatively low among the patients of APROCO-COPILOTE cohort, this study's results underline a clinically important problem in HIV-infected patients receiving cART. Furthermore, our findings not only emphasize the importance of comprehensive care, especially for socially vulnerable patients, but may also help future studies designed to assess the effectiveness of interventions in reducing the risk of PE during cART.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22544079     DOI: 10.3851/IMP2102

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  6 in total

1.  Clinical correlates of depression chronicity among people living with HIV: What is the role of suicidal ideation?

Authors:  Griffin A Tyree; Florin Vaida; Sidney Zisook; William C Mathews; David J Grelotti
Journal:  J Affect Disord       Date:  2019-07-30       Impact factor: 4.839

2.  Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data.

Authors:  Katie R Mollan; Marlene Smurzynski; Joseph J Eron; Eric S Daar; Thomas B Campbell; Paul E Sax; Roy M Gulick; Lumine Na; Lauren O'Keefe; Kevin R Robertson; Camlin Tierney
Journal:  Ann Intern Med       Date:  2014-07-01       Impact factor: 25.391

Review 3.  Housing Status, Medical Care, and Health Outcomes Among People Living With HIV/AIDS: A Systematic Review.

Authors:  Angela A Aidala; Michael G Wilson; Virginia Shubert; David Gogolishvili; Jason Globerman; Sergio Rueda; Anne K Bozack; Maria Caban; Sean B Rourke
Journal:  Am J Public Health       Date:  2015-11-12       Impact factor: 9.308

4.  Routine depression screening in an HIV clinic cohort identifies patients with complex psychiatric co-morbidities who show significant response to treatment.

Authors:  Joseph E Schumacher; Cheryl McCullumsmith; Michael J Mugavero; Paige E Ingle-Pang; James L Raper; James H Willig; Zhiying You; D Scott Batey; Heidi Crane; Sarah T Lawrence; Charles Wright; Glenn Treisman; Michael S Saag
Journal:  AIDS Behav       Date:  2013-10

5.  Rates and risk factors for suicidal ideation, suicide attempts and suicide deaths in persons with HIV: a systematic review and meta-analysis.

Authors:  Matt Pelton; Matt Ciarletta; Holly Wisnousky; Nicholas Lazzara; Monica Manglani; Djibril M Ba; Vernon M Chinchillli; Ping Du; Anna E Ssentongo; Paddy Ssentongo
Journal:  Gen Psychiatr       Date:  2021-04-09

6.  Prevalence, Recurrence, and Incidence of Current Depressive Symptoms among People Living with HIV in Ontario, Canada: Results from the Ontario HIV Treatment Network Cohort Study.

Authors:  Stephanie K Y Choi; Eleanor Boyle; John Cairney; Evan J Collins; Sandra Gardner; Jean Bacon; Sean B Rourke
Journal:  PLoS One       Date:  2016-11-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.